Publikationen
_{^{Massenspektrometrie}}

Klag, K.; Ott, D.; Tippetts, S.; Nicolson, R.; Tatum, S.; Bauer, K.; Stephen-Victor, E.; Weis, A.; Bell, R.; Weagley, J. et al.; Maschek, A.; Vu, D.; Heaver, S.; Ley, R.; O'Connell, R.; Holland, W.; Summers, S.; Stephens, W.; Round, J.: Dietary fat disrupts a commensal-host lipid network that promotes metabolic health. Cell Metabolism 38 (1), S. 157 - 173 (2026)

Suzuki, T.; Akbuğa-Schön, T.; Waters, J.; Jakob, D.; Vu, D.; Ballinger, M.; Di Rienzi, S.; Chang, H.; de Araujo, I.; Tyakht, A. et al.; Ley, R.: Selection and transmission of the gut microbiome alone can shift mammalian behavior. Nature Communications 16, 9482 (2025)

Mirretta Barone, C.; Heaver, S.; Gruber, L.; Zundel, F.; Vu, D.; Ley, R.: Spatially resolved lipidomics shows conditional transfer of lipids produced by Bacteroides thetaiotaomicron into the mouse gut. Cell Host & Microbe 32 (6), S. 1025 - 1036 (2024)

Akbuğa-Schön, T.; Suzuki, T.; Jakob, D.; Vu, D.; Waters, J.; Ley, R.: The keystone gut species Christensenella minuta boosts gut microbial biomass and voluntary physical activity in mice. mBio 15 (2), e0283623 (2024)

Heaver, S.; He, H.; Tang, P.; Baslé, A.; Mirretta Barone, C.; Vu, D.; Waters, J.; Marles-Wright, J.; Johnson, E.; Campopiano, D. et al.; Ley, R.: Characterization of inositol lipid metabolism in gut-associated Bacteroidetes. Nature Microbiology 7 (7), S. 986 - 1000 (2022)

Huus, K.; μHEAT Clinical Study Group; Tan, Y.; Abo, H.; Keller, R.; Atay, E.; Dauser, S.; Vu, D.; Prokipchuk, A.; Tyakht, A. et al.; Youngblut, N.; Chassaing, B.; Kang, S.-M.; Parsonnet, J.; Kremsner, P.; Maier, L.; Gewirtz, A.; Esen, M.; Ley, R.: Flagellin in the human gut microbiome is a diet-adjustable adjuvant for vaccination. In 6th Novel Concepts in Innate Immunity, LT 6-1. 6th Novel Concepts in Innate Immunity, Tübingen, Germany, 10. Juni 2025 - 13. Juni 2025. (2025)

Hipp, K.; Vu, D.: Being a Scientist in a Facility: Challenges and Opportunities. Career Seminar Series, Tübingen, Germany (2023)

Huus, K.; µHEAT Clinical Study Group; Abo, H.; Tan, Y.; Atay, E.; Keller, R.; Dauser, S.; Vu, D.; Jakob, D.; Prokipchuk, A. et al.; Liu, R.; Tyakht, A.; Youngblut, N.; Chassaing, B.; Kang, S.-M.; Parsonnet, J.; Kremsner, P.; Maier, L.; Gewirtz, A.; Esen, M.; Ley, R.: The human gut microbiome primes fever after vaccination. IMPACTT 5: Advancing Microbiome Research, Canmore, AB, Canada (2025)

Heaver, S.; Vu, D.; Bryson, A.; Ley, R.: A parallel pathway for inositol sphingolipid synthesis in gut Bacteroidota. 75th Mosbacher Kolloquium "The Microbiome - from Understanding to Modulation", Mosbach, Germany (2024)

Heaver, S.; Vu, D.; Laugner, S.; Ley, R.: A novel parallel pathway for inositol sphingolipid synthesis in gut Bacteroidota. 3rd International Conference Controlling Microbes to Fight Infections (CMFI 2023), Tübingen, Germany (2023)

Heaver, S.; Vu, D.; Laugner, S.; Ley, R.: A novel parallel pathway for inositol sphingolipid synthesis in gut Bacteroidetes. Cell Symposia: Infection Biology in the Age of the Microbiome, Paris, France (2023)

Huus, K.; μHEAT Clinical Study Group; Tan, Y.; Abo, H.; Keller, R.; Atay, E.; Vu, D.; Dauser, S.; Prokipchuk, A.; Tyakht, A. et al.; Youngblut, N.; Chassaing, B.; Kang, S.-M.; Parsonnet, J.; Kremsner, P.; Maier, L.; Gewirtz, A.; Esen, M.; Ley, R.: Flagellin in the human gut microbiome is a diet-adjustable adjuvant for vaccination. (eingereicht)